Search Results 481-490 of 1725 for 批改网ai写作,ai写作的网文,ai画图的网址,下载ai 的网站,ai音乐生成网址,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

  1. Brightline-1: A Study to Compare Bi 907828 With Doxorubicin In People With a Type of Cancer Called Dedifferentiated Liposarcoma - Mayo Clinic

    Doxorubicin is a medicine already used to treat cancer including liposarcoma. During the study, participants get either BI 907828 or doxorubicin. Every 3 weeks, ...

  2. Xiaogang Li, Ph.D. - Mayo Clinic Faculty Profiles

    Xiaogang Li, Ph.D., conducts research at Mayo Clinic on polycystic kidney disease (PKD), cyst formation, epigenetics and inflammation.

  3. Evaluation of Rate Adaptive Pacing on Chronotropic Response in Preserved Ejection Fraction HF - Mayo Clinic

    About this study. RESPOND-HF is a prospective, multi-center, non-significant risk pilot study with cross-over design. The purpose of the study is to ...

  4. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

  5. Licensed Technology - Biliary Regenerative Medicine: Robert C. Huebert - Mayo Clinic Research

    The Biliary Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic, has developed a transformed sinusoidal endothelial cell (TSEC) line.

  6. Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia - Mayo Clinic

    The purpose of this study is to test any good and bad effects of adding the drug Blinatumomab to different doses of standard combination of chemotherapy drugs.

  7. Collaborators - Molecular Analysis of Human Diseases Laboratory - Mayo Clinic Research

    Collaborators. Dr. Hawse is involved in ongoing research collaborations at Mayo Clinic and other institutions. Mayo Clinic collaborators. Breast cancer.

  8. An Extension Study to Assess Long-Term Safety of Eplontersen in Adults with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. An Optimized Ultrasound Twinkling Marker For The Imaging Of Lymph Nodes In Patients With Clinically Node-Positive Breast Cancer, The UTMOST2 Trial - Mayo Clinic

    In patients with biopsy-proven breast cancer, biopsy markers are used to identify the sites of cancer involvement in both the breasts and lymph nodes. These ...

  10. A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer - Mayo Clinic

    A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer · Overview · Participation eligibility.